Association of Umbilical Cord Milking vs Delayed Umbilical Cord Clamping With Death or Severe Intraventricular Hemorrhage Among Preterm Infants.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
19 11 2019
Historique:
entrez: 20 11 2019
pubmed: 20 11 2019
medline: 28 11 2019
Statut: ppublish

Résumé

Umbilical cord milking as an alternative to delayed umbilical cord clamping may provide equivalent benefits to preterm infants, but without delaying resuscitation. To determine whether the rates of death or severe intraventricular hemorrhage differ among preterm infants receiving placental transfusion with umbilical cord milking vs delayed umbilical cord clamping. Noninferiority randomized clinical trial of preterm infants (born at 23-31 weeks' gestation) from 9 university and private medical centers in 4 countries were recruited and enrolled between June 2017 and September 2018. Planned enrollment was 750 per group. However, a safety signal comprising an imbalance in the number of severe intraventricular hemorrhage events by study group was observed at the first interim analysis; enrollment was stopped based on recommendations from the data and safety monitoring board. The planned noninferiority analysis could not be conducted and a post hoc comparison was performed instead. Final date of follow-up was December 2018. Participants were randomized to umbilical cord milking (n = 236) or delayed umbilical cord clamping (n = 238). The primary outcome was a composite of death or severe intraventricular hemorrhage to determine noninferiority of umbilical cord milking with a 1% noninferiority margin. Among 540 infants randomized, 474 (88%) were enrolled and completed the trial (mean gestational age of 28 weeks; 46% female). Twelve percent (29/236) of the umbilical cord milking group died or developed severe intraventricular hemorrhage compared with 8% (20/238) of the delayed umbilical cord clamping group (risk difference, 4% [95% CI, -2% to 9%]; P = .16). Although there was no statistically significant difference in death, severe intraventricular hemorrhage was statistically significantly higher in the umbilical cord milking group than in the delayed umbilical cord clamping group (8% [20/236] vs 3% [8/238], respectively; risk difference, 5% [95% CI, 1% to 9%]; P = .02). The test for interaction between gestational age strata and treatment group was significant for severe intraventricular hemorrhage only (P = .003); among infants born at 23 to 27 weeks' gestation, severe intraventricular hemorrhage was statistically significantly higher with umbilical cord milking than with delayed umbilical cord clamping (22% [20/93] vs 6% [5/89], respectively; risk difference, 16% [95% CI, 6% to 26%]; P = .002). In this post hoc analysis of a prematurely terminated randomized clinical trial of umbilical cord milking vs delayed umbilical cord clamping among preterm infants born at less than 32 weeks' gestation, there was no statistically significant difference in the rate of a composite outcome of death or severe intraventricular hemorrhage, but there was a statistically significantly higher rate of severe intraventricular hemorrhage in the umbilical cord milking group. The early study termination and resulting post hoc nature of the analyses preclude definitive conclusions. ClinicalTrials.gov Identifier: NCT03019367.

Identifiants

pubmed: 31742630
pii: 2755614
doi: 10.1001/jama.2019.16004
pmc: PMC6865839
doi:

Banques de données

ClinicalTrials.gov
['NCT03019367']

Types de publication

Equivalence Trial Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1877-1886

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD088646
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

JAMA Pediatr. 2015 Jul;169(7):631-8
pubmed: 26010418
N Engl J Med. 2010 May 27;362(21):1970-9
pubmed: 20472939
Pediatrics. 2012 Mar;129(3):480-4
pubmed: 22371462
J Matern Fetal Neonatal Med. 2019 Feb;32(3):477-482
pubmed: 28934915
Pediatr Res. 2002 Mar;51(3):310-6
pubmed: 11861935
PLoS One. 2015 Sep 21;10(9):e0138829
pubmed: 26390401
Clin Perinatol. 2014 Mar;41(1):47-67
pubmed: 24524446
Pediatr Res. 2007 Apr;61(4):467-73
pubmed: 17515873
Eur J Obstet Gynecol Reprod Biol. 2017 May;212:144-149
pubmed: 28363188
N Engl J Med. 2017 Dec 21;377(25):2445-2455
pubmed: 29081267
J Pediatr. 1978 Apr;92(4):529-34
pubmed: 305471
Am J Obstet Gynecol. 2018 Jan;218(1):1-18
pubmed: 29097178
JAMA Pediatr. 2015 Jan;169(1):18-25
pubmed: 25365246
Arch Dis Child Fetal Neonatal Ed. 2018 Nov;103(6):F539-F546
pubmed: 29208663
Pediatrics. 2015 Jul;136(1):61-9
pubmed: 26122803
Sci Rep. 2018 Apr 25;8(1):6511
pubmed: 29695729
J Pediatr. 2018 Mar;194:76-80
pubmed: 29246467

Auteurs

Anup Katheria (A)

Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, California.

Frank Reister (F)

Department of Obstetrics, University of Ulm, Ulm, Germany.

Jochen Essers (J)

Department of Pediatrics, University of Ulm, Ulm, Germany.

Marc Mendler (M)

Department of Pediatrics, University of Ulm, Ulm, Germany.

Helmut Hummler (H)

Division of Neonatology, Department of Pediatrics, Sidra Medicine, Doha, Qatar.

Akila Subramaniam (A)

Department of Obstetrics, University of Alabama at Birmingham.

Waldemar Carlo (W)

Department of Pediatrics, University of Alabama at Birmingham.

Alan Tita (A)

Department of Obstetrics, University of Alabama at Birmingham.

Giang Truong (G)

Department of Pediatrics, Loma Linda University, Loma Linda, California.

Shareece Davis-Nelson (S)

Department of Obstetrics, Loma Linda University, Loma Linda, California.

Georg Schmölzer (G)

Department of Pediatrics, University of Alberta, Edmonton, Canada.

Radha Chari (R)

Department of Obstetrics, University of Alberta, Edmonton, Canada.

Joseph Kaempf (J)

Women and Children's Services, Providence St Vincent Medical Center, Portland, Oregon.

Mark Tomlinson (M)

Women and Children's Services, Providence St Vincent Medical Center, Portland, Oregon.

Toby Yanowitz (T)

Department of Pediatrics, Magee Women's Hospital of UPMC, Pittsburgh, Pennsylvania.

Stacy Beck (S)

Department of Obstetrics, Magee Women's Hospital of UPMC, Pittsburgh, Pennsylvania.

Hyagriv Simhan (H)

Department of Obstetrics, Magee Women's Hospital of UPMC, Pittsburgh, Pennsylvania.

Eugene Dempsey (E)

Department of Paediatrics and Child Health, University College Cork, Cork, Ireland.
INFANT Research Centre, University College Cork, Cork, Ireland.

Keelin O'Donoghue (K)

Department of Obstetrics, University College Cork, Cork, Ireland.

Shazia Bhat (S)

Department of Pediatrics, Christiana Care Health System, Newark, Delaware.

Matthew Hoffman (M)

Department of Obstetrics, Christiana Care Health System, Newark, Delaware.

Arij Faksh (A)

Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, California.

Kathy Arnell (K)

Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, California.

Wade Rich (W)

Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, California.

Neil Finer (N)

Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns, San Diego, California.

Yvonne Vaucher (Y)

Department of Radiology, Children's Hospital Colorado, University of Colorado School of Medicine, Denver.

Paritosh Khanna (P)

Department of Radiology, Rady Children's Hospital, San Diego, California.

Mariana Meyers (M)

Department of Radiology, Children's Hospital Colorado, University of Colorado School of Medicine, Denver.

Michael Varner (M)

Department of Obstetrics and Gynecology, University of Utah, Salt Lake City.

Phillip Allman (P)

Department of Biostatistics, University of Alabama at Birmingham.

Jeff Szychowski (J)

Department of Biostatistics, University of Alabama at Birmingham.

Gary Cutter (G)

Department of Biostatistics, University of Alabama at Birmingham.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH